Connect with us

Hi, what are you looking for?


FDA approves Biogen’s Alzheimer’s drug

The drug, Aduhelm, had received mixed reviews following earlier clinical trials

By Alexandria Hein


The Food and Drug Administration (FDA) on Monday approved Biogen’s Alzheimer’s drug, marking the first new authorized therapy to treat the disease in nearly two decades. The drug, Aduhelm (aducanumab), had received mixed reviews following earlier clinical trials.

In a statement following the approval, Dr. Patrizia Cavazzoni, director of the FDA Center for Drug Evaluation and Research, said the agency used the Accelerated Approval pathway, which is when the FDA “approves a drug for a serious or life-threatening illness that may provide…

Click the link below to read the rest of this story.

Click here to get more news from the Bulldog

On the go, but don’t want to miss any Bulldog news? Go to the App Store and downloads apps for Bulldog Reports and The Bulldog Show to your Apple and Android mobile devices. It’s free!

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Bulldog Regional/Local

Kentucky State Police have confirmed they are conducting an investigation into the allegations

National News

By Mark Hansel Bulldog Report managing editor The inaugural Freedom Fest in Morning View, Kentucky, drew a crowd of thousands to the farm of...


Also , Begged Joe To Run For WH To Salvage His Own Reputation And Made Porn Films With Prostitutes. Forensic Experts Prove Laptop IS...


Letter from St. E doctors and other healthcare professionals expresses strong opposition to mandate Deters law has received a copy of a letter from...